This article was originally published in The Tan Sheet
Richard Paul, MD, named VP-clinical research. He most recently served as executive director of clinical research for Sandoz' consumer products division and also has held posts with Pfizer and BOC Healthcare
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC